WASHINGTON — The Food and Drug Administration approved two new products Wednesday designed to help deal with the consequences of terrorists using dirty bombs.
Don't miss these Health stories
More women opting for preventive mastectomy - but should they be?
- Larry Page's damaged vocal cords: Treatment comes with trade-offs
- Report questioning salt guidelines riles heart experts
- CDC: 2012 was deadliest year for West Nile in US
- What stresses moms most? Themselves, survey says
- More women opting for preventive mastectomy - but should they be?
Acting FDA Commissioner Lester M. Crawford told The Associated Press that the products, to be available by prescription only, are designed to speed up elimination of radiation from the body.
Dirty bombs have become an increasing concern. Unlike warheads designed to kill and destroy through a huge nuclear blast and heat, so-called dirty bombs are radiation weapons. They would rely on conventional explosives to blow radioactive material far and wide. A successful bomb could make a section of a city uninhabitable for years.
The agency said the goal is to provide protection from both nuclear accidents and threats. It said the two drugs are safe and effective for treating contamination from the elements plutonium, americium or curium.
The FDA said that while these drugs have been in use on an experimental basis for several years, until this action there have been no approved drugs for treatment of internal contamination by the three radioactive elements.
Plutonium, americium or curium can enter the body through a variety of routes including ingestion, inhalation or direct contact through wounds. By removing them quickly the victim may avoid possible future effects including the development of certain cancers, which may occur years after exposure, FDA said.
- Penetate calcium trisodium injection, Ca-DTPA.
- Zinc trisodium injection, Zn-DTPA.
© 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.